Icagen Inc

Icagen, Inc. (ICAgen) is a biopharmaceutical company engaged in discovering, developing and commercializing the orally administered small molecule drugs that modulate ion channel targets. It also focuses conducting on clinical and preclinical studies in core areas like Epilepsy and Pain, Senicapoc, Pain Control and Inflammatory Disorders. Its two most advanced programs are ICA-105665 for epilepsy and neuropathic pain and Senicapoc, for asthma. In addition, the Company also conducts research and development activities on disease areas such as including epilepsy; pain and inflammation. It is headquartered at Durham in North Carolina, United States.

Street: 
4222 Emperor Boulevard,
City: 
Durham
Postcode: 
27703
Federal State : 
United States
WebSite: 
www.icagen.com
Fax: 
1-919-9410813

Company Index Score

Current Index Score Historical Index Score
  • Icagen Inc currently scores 50 % in the index.
  • Icagen Inc is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Icagen Inc is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets